FDA didn't disclose safety panel's ties to Bayer, WSJ says

When an FDA advisory panel voted to support Bayer's birth control pills after new data emerged on their potential to cause blood clots, the agency didn't disclose that three of the committee members have served as consultants, speakers, or researchers for the German company, The Wall Street Journal reports. Report

Suggested Articles

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…

Biogen plans to test its SMA drug Spinraza at a higher-than-approved dose as Novartis' rival gene therapy Zolgensma picks up traction.